Clinical Trials Sponsored by Beijing Chest Hospital

Total 3392 results

Shanghai Chest Hospital

Unknown

Recombinant BNP on Heart and Renal Function in Acute Heart Failure

Acute Renal Failure | Acute Heart Failure

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) (BLESS)

Esophageal Cancer

China
Shanghai Chest Hospital

Recruiting

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Carcinoma | Non-small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Association of Psychological Distress in Patients With Lung Cancer (Life-Score)

Lung Neoplasms | Psychological Distress | IMMUNOTHERAPY | Lifestyle, Healthy | Targeted Molecular Therapy | Prognosis Factors

China
Shanghai Chest Hospital

Not yet recruiting

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Recruiting

Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs

Peripheral Pulmonary Nodules

China
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Shanghai Chest Hospital

Not yet recruiting

Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. (CAMFA-L)

NSCLC

China
Shanghai Chest Hospital

Not yet recruiting

Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (ATTACK)

NSCLC
Shanghai Chest Hospital

Not yet recruiting

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NRG1-fused Non-small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Non-small-cell Lung Cancer

China
Tianjin Chest Hospital

Recruiting

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome (EMSIACS)

Acute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

China
Shanghai Chest Hospital

Completed

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Completed

Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement

Persistent Atrial Fibrillation | Right Atrial Enlargement

China
Shanghai Chest Hospital

Unknown

Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer

SCLC | Anlotinib

China
Shanghai Chest Hospital

Unknown

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Recurrence | Metastasis | Esophageal Squamous Cell Carcinoma | Apatinib

China
Shanghai Chest Hospital

Completed

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

Lung Cancer

China
Shanghai Chest Hospital

Unknown

To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation

Lung Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Unknown

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

Carcinoma | Non-small Cell Lung Cancer
Shanghai Chest Hospital

Completed

UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS

Ultrasonography
Shanghai Chest Hospital

Unknown

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC (HCFCCUSN)

Unresectable Stage III Non-small-cell Lung Cancer

China
Tianjin Chest Hospital

Unknown

Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.

Percutaneous Coronary Intervention | Saphenous Vein Graft Disease | Major Adverse Cardiovascular Events | Virtual Histology Intravascular Ultrasound

China
Shanghai Chest Hospital

Unknown

ENB Guided RFA for Early-stage Peripheral Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations

NSCLC | SBRT | GM-CSF

China
Shanghai Chest Hospital

Unknown

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

NSCLC

China
Shanghai Chest Hospital

Unknown

Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

Esophageal Cancer | Chemoradiation | Surgery

China
Shanghai Chest Hospital

Unknown

Percutaneous Cryoablation Peripheral Lung Cancer (PCPLC)

Lung Cancer
Shanghai Chest Hospital

Unknown

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) (EGFR)

Non-Small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

China
Shanghai Chest Hospital

Recruiting

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma | Unresectable Locally Advanced Esophageal Cancer

China
Shanghai Chest Hospital

Not yet recruiting

A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema (BTVA)

Severe Emphysema
Shanghai Chest Hospital

Recruiting

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Cancer | Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation

Atrial Fibrillation | Cathter Ablation | Endpoint

China
Shanghai Chest Hospital

Recruiting

Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial (MR)

Lung Cancer

China
Tianjin Chest Hospital

Recruiting

Optimal Evaluation to Reduce Imaging Testing (OPERATE)

Chronic Coronary Syndrome

China
Shanghai Chest Hospital

Not yet recruiting

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) (RICE)

Chemotherapy | Immunotherapy | Concurrent Chemoradiotherapy | Esophageal Squamous Cell Carcinomas
Shanghai Chest Hospital

Not yet recruiting

Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation

Atrial Fibrillation | Catheter Ablation
Anhui Chest Hospital

Not yet recruiting

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Shanghai Chest Hospital

Recruiting

mCBCT in Combination With ENB for the Diagnosis of PPNs

Lung Cancer | Peripheral Pulmonary Nodules

China
Shanghai Chest Hospital

Recruiting

China Lung Cancer Screening (CLUS) Study Version 3.0

Lung Cancer

China
Shanghai Chest Hospital

Recruiting

First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations

Non-Small Cell Lung Cancer (NSCLC)

China
Shanghai Chest Hospital

Not yet recruiting

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

NSCLC, Stage III
Shanghai Chest Hospital

Not yet recruiting

Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection (ARPL)

Lung Cancer | SPN
Shanghai Chest Hospital

Not yet recruiting

Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer (APEC)

Esophageal Cancer

3

Subscribe